Table 2.
H1: Type III Fixed Effects for Treatment Services while Controlling for Covariates
| Source | Treatment Initiationa | Treatment Engagementb | Continuing Carec | |||
|---|---|---|---|---|---|---|
| df | F-test (p) | df | F-test (p) | df | F-test (p) | |
| Site pairs | 9,10 | 0.53 (.82) | 8,8 | 4.09 (.03) | 8,7 | .97 (.52) |
| Study Phase | 4,7973 | 10.29 (< .0001) | 4,6010 | 10.55 (< .0001) | 4,5924 | 9.53 (< .0001) |
| Male | 1,7973 | 3.06 (.09) | 1,6010 | 0.03 (.87) | 1,5924 | 0.04 (.85) |
| White | 1,7973 | 17.21 (< .0001) | 1,6010 | 6.07 (.01) | 1,5924 | 5.58 (.02) |
| Probation | 1,7973 | 200.50 (< .0001) | 1,6010 | 76.82 (< .0001) | 1,5924 | 58.40 (< .0001) |
| Positive Urine | 1,7973 | 41.80 (< .0001) | 1,6010 | 24.87(< .0001) | 1,5924 | 19.31 (< .0001) |
| Maximum Charge Level | 1,7973 | 0.15 (.71) | 1,6010 | 1.41 (.24) | 1,5924 | 2.10 (.15) |
| % Urbanicity | 1,7973 | 0.67 (.42) | 1,6010 | 5.16 (.03) | 1,5924 | 4.37 (.04) |
Note. Probation = Whether or not being on probation. Positive Urine = Whether or not having a positive urine screen. % Urbanicity = Percentage of residents in urban areas. Bold means p < .05
a Treatment Initiation: χ2(1) = 1738.63, p < 0.0001, site variance: 0.03 (0.01), Z = 3.00, p = 0.001, residual variance: 0.13 (0.002), Z = 66.96, p < 0.0001, ES = .01
b Treatment Engagement: χ2(1) = 551.77, p < 0.0001, site variance: 0.01 (0.004), Z = 2.72, p = 0.003, residual variance: 0.08 (0.001), Z = 59.17, p < 0.0001, ES = .01
c Continuing Care: χ2(1) = 264.71, p < 0.0001, site variance: 0.003 (0.001), Z = 2.47, p = 0.007, residual variance: 0.05 (0.001), Z = 58.60, p < 0.0001, ES = .03